Loading stock data…
Globus Medical, Inc. (GMED)
$83.94-2.31 (-2.68%)
After Hours$83.72-0.22 (-0.26%)· Last close Jun 29
Globus Medical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Globus Medical, Inc. in the Healthcare sector is trading at $83.94 with a market capitalization of $10.6B. Wall Street consensus targets $108.64 (11 analysts), implying a +29.4% move over the next 12 months. The stock is currently 17% below its 52-week high of $101.40, remaining 2.9% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +29.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $759.85M↓ | $826.42M↑ | $769.05M↑ | $745.34M↑ | $598.12M |
| Gross Profit | $525.79M↓ | $565.31M↑ | $516.51M↑ | $496.58M↑ | $402.72M |
| Operating Income | $161.98M↓ | $181.31M↑ | $135.01M↑ | $122.81M↑ | $98.06M |
| Net Income | $124.30M↓ | $140.59M↑ | $118.97M↓ | $202.85M↑ | $75.46M |
Peer Comparison
JNJUNHPFE
Fundamentals
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle scre...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.58B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
18.21
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.00
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.40%
Volume
Today's trading volume
1.18M
Recent News
Globus Medical (GMED) Stock After 47% One-Year Gain Is There More Room To Run
If you are wondering whether Globus Medical stock still offers value at around US$86.25, the key question is how its current price lines up against what the business may be worth. The share price has moved sharply at times, with a 7 day return of 8.9%, 30 day return of 5.3%, year to date return down 1.2%, and a 1 year return of 47.2%, while the 3 year and 5 year returns stand at 44.9% and 9.5% respectively. Recent market attention on Globus Medical has focused on its role in the medical...
Veeva Expands Quality Cloud With New EHS Risk Management Solution
VEEV's Veeva EHS expands Quality Cloud with automated risk, compliance and safety workflows, aiming to replace legacy systems with a unified platform.
Should You Hold Chemed Stock in Your Portfolio Now?
CHE's VITAS growth and Roto-Rooter improvements support its outlook, but inflation, tariffs and competitive pressures remain key risks.
Neogen Gains 101.1% in a Year: What's Driving the Rally?
NEOG has surged as Food Safety growth, product launches and 3M integration support higher fiscal 2026 revenue guidance despite cost pressures.
Is it the Right Time to Add Labcorp Stock to Your Portfolio?
LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.